Informations générales
  • Catégorie de maladie Cancer colorectal , Autres cancer (BASEC)
  • État du recrutement Inconnu (BASEC/ICTRP)
  • Lieu de l’étude
    Winterthur
    (BASEC)
  • Responsable de l'étude PD Dr. Dr. med. Lukasz Filip Grochola lukaszfilip.grochola@ksw.ch (BASEC)
  • Source(s) de données BASEC: Importé de 08.01.2025 ICTRP: N/A
  • Date de mise à jour 08.01.2025 16:08
HumRes66119 | SNCTP000006186 | BASEC2024-D0088

What effects does radiofrequency have in liver surgeries? Can it help prevent cancer recurrence?

  • Catégorie de maladie Cancer colorectal , Autres cancer (BASEC)
  • État du recrutement Inconnu (BASEC/ICTRP)
  • Lieu de l’étude
    Winterthur
    (BASEC)
  • Responsable de l'étude PD Dr. Dr. med. Lukasz Filip Grochola lukaszfilip.grochola@ksw.ch (BASEC)
  • Source(s) de données BASEC: Importé de 08.01.2025 ICTRP: N/A
  • Date de mise à jour 08.01.2025 16:08

Résumé de l'étude

Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer-related death. Furthermore, the liver is also the primary site for metastases from colorectal cancer, which is the third most common malignant disease worldwide. The standard treatment for liver cancer and liver metastases from colorectal cancer is the surgical removal of the tumor-bearing part of the liver. However, after such surgeries, cancer often recurs. Further research is needed to find a solution to this problem. It may help to treat the tumor margins after surgery with a radiofrequency device to reduce the number of tumor recurrences. This method applies high-frequency electromagnetic waves to the tissue at the tumor margins. The device heats the tissue and thereby kills cancer cells that may have remained after surgery. In the study, participants are randomly assigned to two groups. In the experimental group, liver cell cancer or liver metastases are surgically removed and the tumor margins are additionally cauterized using radiofrequency. In the control group, the cancer is only surgically removed. No additional treatment of the tumor margins is performed. Only the study staff will know which group the participants were assigned to. The aim of the study is to determine whether the additional cauterization of the tumor margins with a radiofrequency device can reduce the local recurrence rate of this cancer.

(BASEC)

Intervention étudiée

Surgical removal of liver cell cancer or liver metastases from colon cancer. In the experimental group, the tumor margins are also cauterized using radiofrequency, while in the control group no further treatment of the tumor margins is performed.

(BASEC)

Maladie en cours d'investigation

Liver cell cancer or liver metastases caused by colon or rectal cancer

(BASEC)

Critères de participation
1. Written consent after detailed information about the study 2. 18 years or older 3. WHO Performance Status: 0-2 4. Continuous inclusion of patients (evenly distributed between both sexes) with liver metastases from colorectal cancer or patients with liver cell tumors. 5. Previous chemotherapies are allowed 6. ASA (American Society of Anesthesiology Classification) classification of the patient: 1-3 (BASEC)

Critères d'exclusion
1. Previous or concurrent cancers that are not the primary tumor of the liver metastases, except for early-stage cervical cancer, treated skin cancer, or superficial bladder tumors. Cancers successfully treated more than 3 years ago are allowed. 2. ASA (American Society of Anesthesiology Classification) classification of the patient: 4 3. Unresectable metastases outside the liver 4. Liver metastases not originating from colorectal cancer 5. The primary liver tumor must not be benign (BASEC)

Lieu de l’étude

Winterthur

(BASEC)

non disponible

Sponsor

non disponible

Contact pour plus d'informations sur l'étude

Personne de contact en Suisse

PD Dr. Dr. med. Lukasz Filip Grochola

+41522664162

lukaszfilip.grochola@ksw.ch

(BASEC)

Informations scientifiques

non disponible

Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)

Commission cantonale de Zurich

(BASEC)

Date d'approbation du comité d'éthique

22.11.2024

(BASEC)


Identifiant de l'essai ICTRP
non disponible

Titre officiel (approuvé par le comité d'éthique)
non disponible

Titre académique
non disponible

Titre public
non disponible

Maladie en cours d'investigation
non disponible

Intervention étudiée
non disponible

Type d'essai
non disponible

Plan de l'étude
non disponible

Critères d'inclusion/exclusion
non disponible

non disponible

Critères d'évaluation principaux et secondaires
non disponible

non disponible

Date d'enregistrement
non disponible

Inclusion du premier participant
non disponible

Sponsors secondaires
non disponible

Contacts supplémentaires
non disponible

ID secondaires
non disponible

Résultats-Données individuelles des participants
non disponible

Informations complémentaires sur l'essai
non disponible


Résultats de l'essai

Résumé des résultats

non disponible

Lien vers les résultats dans le registre primaire

non disponible